[ad_1]
John Nation / STAR MAX / IPx
Pfizer Announces: Ready for November to Request Authorization for its Covid Vaccine. Burioni is delighted and relaunches the letter to the CEO of the pharmaceutical company. “We have an appointment. Albert Bourla, CEO of Pfizer, writes that, hopefully, he will submit an emergency authorization request for the Covid-19 vaccine in the third week of November 2020. Let’s go!”
We have a date. Albert Bourla, CEO of Pfizer, writes that he will hopefully submit an emergency clearance request for the COVID-19 vaccine in the third week of November 2020. Let’s go! https://t.co/uFyN0jLzLzpic.twitter.com/hopP1tOB4g
– Roberto Burioni (@RobertoBurioni) October 16, 2020
I wanted to speak – says Albert Bourla – before billions of people, millions of companies and hundreds of governments around the world who are investing their hopes in a safe and effective vaccine to overcome this pandemic. I know there is confusion about what it will take to get approval and given critical public health considerations and the importance of transparency I would like to provide more clarity on the timelines for Pfizer regarding our COVID-19 vaccine from partner BioNTech . “.
“We could know if our vaccine is effective – explains the general director – or not at the end of October. To do this, we need to accumulate a series of Covid 19 cases in our study to compare the effectiveness of the vaccine in vaccinated individuals with those who received a placebo. As we have to wait for several cases to occur, this data may arrive sooner or later, depending on changes in infection rates. A committee of independent scientists will review the complete data and inform us if the vaccine is effective or not based on predetermined criteria ”.
[ad_2]
